TACI – SUPER Low Float Report!

Recommended Stock Newsletters
#1. PennyStockWarfare
#2. Nova Stocks
#3. Penny Stock Finder

OTCtipReporter Newsletter

Dear Fellow Trader, As promised, we have a BRAND NEW ALERT Ready to Go! My New Breakout Play is:

TransAtlantic Capital Inc. (TACI) Symbol: TACI Co: TransAtlantic Capital Inc. (TACI) Website: www.epicos.com TACI Is On Immediate ALERT! About TransAtlantic Capital Inc.

TransAtlantic Capital Inc. develops and markets products for the detection of military and commercial explosives for the homeland security market. Acrosec Ltd. (Acrosec) is the Company`s wholly owned subsidiary. The Company`s first product is called the Peroxide Explosives Tester (ACRO-P.E.T.). ACRO-P.E.T. is a small, disposable, pen-like probe, which detects the presence of peroxide-based explosives using three chemical solutions and relies on direct contact with the suspicious substance. ACRO-P.E.T. has been designed for on-site detection of peroxide-based explosives.

In addition, the Company developed the ACRO-N.E.T. (Nitride Explosives Tester), which detects the presence of commercial and military explosives.

This Is Why Smart Traders Are About to Pounce On TACI! TACI has pulled back from a recent high of $25.00, and is now trading around $2.50! TACI recently ran from a little over $5.00 to a whopping $25.00 PPS… YES YOU read that right a whopping $25.00 PPS! If TACI was to test its recent highs that would mean 900% Gains for the record books! These are the times when profits are made, and we strongly suggest that all members act now and pull up TACI while it`s still trading at these lower levels! TACI has a proven history of triple-digit percent bounces, and we have a feeling the next big triple-digit percent bounce is upon us! TACI has a SUPER LOW FLOAT! There can be a super-fast profit opportunity when investing in low float penny stocks.

Some of the most volatile stocks often have lower floats. Due to their volatility these stocks can be capable of major swings.

For those who are unfamiliar with the term float, the float is the amount of shares available to the public.

For example one of our recent low float announcements had a tiny float like TACI and it blew up shortly after our report was sent out. The stock saw gains over +900% within an hour of our release! In investment of $1,000 could have become $10,000 in under an hour that day! Companies with smaller floats are typically much more volatile compared to companies with larger floats. So when you come across a small cap company, that has a float with UNDER 25k shares in it, just a bit of attention could send it SKYROKETING!!! TACI has just under 25k In the Float! KaBOOM! This one will be a mover and fast fingers will win the day!! GO, GO, GO!!! Low float announcements are some of our favorites! If you`re looking for a potential fast moving play with big gain potential, than TACI should be the only alert on your radar! Happy Trading!! The OTCtipReporter Team 100% TRANSPARANCY!!!! I am going to be extremely clear with you on how my newsletter works.

I DON`T FRONTLOAD, BUY or RECEIVE any SHARES of a Company that I Profile!! I NEVER OWN ANY POSITION IN A COMPANY I ALERT/PROFILE!! It would be UNFAIR, WRONG and ILLEGAL for me to have a position in ANY Company I ever Profile on my Newsletter! I just wanted to address this for some people who might think or wonder if I trade the companies I profile on my Newsletter or if I own a position before or during the time I profile them. The 100% honest truth is I DO NOT!!….. I do get CASH compensation to profile companies time to time.

DON`T MISS ANOTHER HOT OPPORTUNITY TO MAKE HUGE PROFITS! Help Spread the word about OTCtipReporter! You can call us toll free at: 1-800-850-9305 Offices are open Monday through Friday, 9:30 am to 4:00 pm EST Email: office@OTCtipReporter.com www.OTCtipReporter.com Investor Awareness and IR Services If you are interested in our Investor Awareness and IR Services Contact us at 1-800-850-9305 or email us at office@OTCtipReporter.com GENERAL NOTICE AND DISCLAIMER – PLEASE READ CAREFULLY The companies that are discussed on OTCtipReporter.com have not approved the statements made. This opinion contains forward-looking statements that involve risks and uncertainties. A company`s actual results could differ materially from those described in any forward-looking statements or announcements discussed herein. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. OTCtipReporter.com is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Nor are any of its officers, affiliates, or employees. Please consult a broker before purchasing or selling any securities viewed on OTCtipReporter.com or mentioned herein.

Affiliates, officers, directors and employees of OTCtipReporter.com may have also bought or may buy shares of companies mentioned herein and may profit in the event those shares rise in value.

OTCtipReporter.com wi ll not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make their own decision based on his or her judgment of the market. This advertisement is not a solicitation or recommendation to buy, sell or hold securities and does not provide an analysis of the financial position of the company. We recommend you use the information found in this advertisement as an initial starting point for conducting your own research on the advertised company in order to determine your own personal opinion of the company before investing. All statements and opinions contained in this advertisement are the sole opinion of the authors and are subject to change without notice. We are not liable for any investment decisions by our readers. Readers should independently investigate and fully understand all risks before investing. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser or broker prior to completing any such purchase or sale decision. We are not registered investment advisers, or broker-dealers, or members of any financial regulatory bodies. Furthermore, our associates and/or employees and/or principals may have stock positions in advertised companies purchased in the open market or in private transactions.

These positions may be liquidated, without prior notification, even after we have made positive comments regarding the advertised company. The receipt of this information constitutes your acceptance of these terms and conditions. Reading this advertisement shall not create under any circumstances an offer to buy or sell stock in any company advertised. Nor shall it create any principal-agent relationship between the reader and us. Void where prohibited. Information within this advertisement contains “forward looking” statements within the meaning of Section-27(a) of the U.S. Securities Act-of-1933 and Section 21(e) of t he U.S.

Securities Exchange Act-of -934. Neither OTCtipReporter.com, its officers, affiliates, or employees is a broker-dealer. The information on OTCtipReporter.com, including the opinions expressed and the statements made within, is for informational and advertising purposes only and should not be construed as investment-advice, and does not constitute an offer to sell any securities, nor is it to be construed as a solicitation to purchase any securities in any state or other jurisdiction where the offer or sale is not permitted. The information to prepare this report is believed to be from reliable sources, but no representation is made as to the accuracy or completeness of such information. Investment in securities carries a high degree of risk and involves risks and uncertainties, which may result in investors losing all of their invested capital. Past performance does not guarantee future results. The information contained herein contains “forward-looking statemen ts,” within the meaning of Section-27A of the Securities Act-of-1933 and Section 21E of the Securities Exchange Act-of-1934.

Forward-looking statements are based upon expectations, estimates and projections at the time the statements are made and involve risks and uncertainties that could cause actual events to differ materially from those anticipated. Forward-looking statements may be identified through the use of words such as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should, or might occur. Any statements that express or involve predictions, expectations, beliefs, plans, projections, objectives, goals or future events or performance may be forward-looking statements. Factors that could cause actual results to differ materially include but are not limited to adverse economic conditions, intense competition, lack of meaningful research results, inadequate capital, termination of contracts or agreements, adv erse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other key personnel, and other risks detailed in the reports filed with the Securities and Exchange Commission by the companies who are mentioned in this periodical. Readers should consult with their own professional investment, tax and portfolio advisors before making any investment decision and should independently verify all information herein.

More complete information about any of the companies mentioned in this periodical is available from the website of the Securities and Exchange Commission, at sec.gov, and copies of their filings may be read without charge and copies obtained at prescribed rates from the public reference facilities of the Commission, at 450 Fifth Street, NW, Washington, DC 20549.

Buying and Selling of Shares OTCtipReporter.com intends to sell its shares. OTCtipReporter.com may sell its shares for less than target prices given in opinions.

OTCtipReporter.com affiliates, officers, directors and employees may have also bought or may buy the shares discussed in this report and may profit in the event those shares rise in value.

OTCtipReporter.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. There are risks involved Always remember that OTCtipReporter.com are not analysts and investing in securities such as the ones listed within are for high risk tolerant individuals only and not the general public. Whether you are an experienced investor or not you should always consult with a broker before purchasing or selling any securities viewed on OTCtipReporter.com. If at any time you wish to be removed from our list simply

This entry was posted in OTCtipReporter.com and tagged , . Bookmark the permalink.

Comments are closed.